118 related articles for article (PubMed ID: 21960573)
1. Rapid reversal of anticoagulation prevents excessive secondary hemorrhage after thrombolysis in a thromboembolic model in rats.
Sun L; Zhou W; Ploen R; Heiland S; Zorn M; Veltkamp R
Stroke; 2011 Dec; 42(12):3524-9. PubMed ID: 21960573
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.
Kono S; Yamashita T; Deguchi K; Omote Y; Yunoki T; Sato K; Kurata T; Hishikawa N; Abe K
Stroke; 2014 Aug; 45(8):2404-10. PubMed ID: 24984746
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.
Ploen R; Sun L; Zhou W; Heitmeier S; Zorn M; Jenetzky E; Veltkamp R
J Cereb Blood Flow Metab; 2014 Mar; 34(3):495-501. PubMed ID: 24346690
[TBL] [Abstract][Full Text] [Related]
5. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
[TBL] [Abstract][Full Text] [Related]
6. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
7. Periprocedural warfarin reversal with prothrombin complex concentrate.
Sridharan M; Wysokinski WE; Pruthi R; Oyen L; Freeman WD; Rabinstein AA; McBane RD
Thromb Res; 2016 Mar; 139():160-5. PubMed ID: 26657301
[TBL] [Abstract][Full Text] [Related]
8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
9. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
[TBL] [Abstract][Full Text] [Related]
10. A translationally relevant thromboembolic stroke model for the study of secondary hemorrhage after thrombolysis in rats.
Sun L; Zhou W; Heiland S; Marti HH; Veltkamp R
Brain Res; 2011 Jan; 1368():346-54. PubMed ID: 20974110
[TBL] [Abstract][Full Text] [Related]
11. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
Sun L; Zhou W; Ploen R; Zorn M; Veltkamp R
Thromb Haemost; 2013 Jul; 110(1):153-61. PubMed ID: 23615682
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.
Majeed A; Eelde A; Agren A; Schulman S; Holmström M
Thromb Res; 2012 Feb; 129(2):146-51. PubMed ID: 21807399
[TBL] [Abstract][Full Text] [Related]
14. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
[TBL] [Abstract][Full Text] [Related]
16. Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2.
Morihara R; Yamashita T; Kono S; Shang J; Nakano Y; Sato K; Hishikawa N; Ohta Y; Heitmeier S; Perzborn E; Abe K
J Neurosci Res; 2017 Sep; 95(9):1818-1828. PubMed ID: 28035779
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment.
Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663
[TBL] [Abstract][Full Text] [Related]
18. SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.
Ito A; Niizuma K; Shimizu H; Fujimura M; Hasumi K; Tominaga T
Brain Res; 2014 Aug; 1578():38-48. PubMed ID: 25016287
[TBL] [Abstract][Full Text] [Related]
19. Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.
Seet RC; Zhang Y; Moore SA; Wijdicks EF; Rabinstein AA
Stroke; 2011 Aug; 42(8):2333-5. PubMed ID: 21659639
[TBL] [Abstract][Full Text] [Related]
20. Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC.
Pfeilschifter W; Spitzer D; Pfeilschifter J; Steinmetz H; Foerch C
PLoS One; 2011; 6(10):e26087. PubMed ID: 22039437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]